Bibliography
- WHO-ISH: 1999 World Health Organization- International Society of hypertension guidelines for the management of hypertension. J. Hypertens. (1999) 17:151–183.
- ••A major national guideline for the management ofhypertension.
- RAMSAY LE, WILLIAMS B, JOHNSTON GD et al.: Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J. Human Hypertens. (1999) 13:569–592.
- ••A major national guideline for the management ofhypertension.
- JNC: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch. Intern. Med. (1997) 157:2443–2446.
- ••A major international guideline for the management ofhypertension.
- Implementing Clinical Guidelines: A Practical Guide. Humphries D, Littlejohns P (Eds.), Radcliffe Medical Press, UK (1999).
- Making Use of Guidelines in Clinical Practice. Hutchinson A, Baker R (Eds.), Radcliffe Medical Press, UK (1999).
- STAESSEN JA, BEILIN L, PARATI G et al. AND THE PARTICI-PANTS OF THE 1999 CONSENSUS CONFERENCE ON AMBULATORY BLOOD PRESSURE MONITORING: Task Force IV: clinical use of ambulatory blood pressure monitoring. Blood Press. Monit. (1999) 4:319–331.
- O'BRIEN E, STAESSEN J: What is hypertension? Lancet (1999) 353:1541–1543.
- ••A paper expressing concern with WHO/ISH guidelines.
- O'BRIEN E, OWENS I, STAESSEN J, IMAI Y, KAWASAKI T,KUWAJIMA I: What are the normal levels of ambulatory blood pressure measurement? Blood Press. Monit. (1998) 3:131–132.
- O'BRIEN F, STAESSEN J: Norrnotension and hyperten-sion as defined 24-h ambulatory blood pressure monitoring. Blood Press. (1995) 4:266–282.
- PICKERING T FOR AN AMERICAN SOCIETY OF HYPERTENSION AD HOC PANEL: Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am. J. Hypertens. (1995) 9:1–11.
- •A major reference for the normal levels of ABPM.
- PORTS, DEMER L, JENNRICH R, WALTER D, GARFINKEL A: Systolic blood pressure and mortality. Lancet (200) 355:175–180.
- •An interesting statistical approach to the level to which blood pressure should be lowered.
- HANSSON L, ZANCHETTI A, CARRUTHERS SG et al. FOR THE HOT STUDY GROUP: Effects of intensive blood pressure lowering and low-dose asprin in patients with hypertension: principle results of the Hyperten-sion Optimal Treatment (HOT) randomised trial. Lancet (1998) 351:1755–1762.
- •A major study on the benefits of lowering blood pressure.
- TERPENING C, GUMS JG, GRAUER K: Management of essential hypertension. Exp. Opin. Pharmacother. (1999) 1(1):71–80.
- •A comparison of JNC VI and WHO/ISH guidelines.
- DAVIS BR, CUTLER JA, GORDON DJ et al.: Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am. J. Hypertens. (1996) 9:342–360.
- DAHLOF B, SEVER P, POULTER NR, WEDEL H ON BEHALF OF THE ASCOT STEERING COMMITTEE. The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am. J. Hypertens. (1998) 11:9A.
- STAESSEN JA, FAGARD R, THUS L etal. FOR THE SYSTOLIC HYPERTENSION IN EUROPE (SYST-EUR) TRIAL INVESTI-GATORS: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet (1997) 350:757–764.
- CLUZEAU F, LITTLEJOHNS P: Assessing the quality ofguidelines. In: Making Use of Guidelines in Clinical Practice. Hutchinson A, Baker R (Eds.), Radcliffe Medical Press, UK (1999):84.
- GRILLI R, MAGRINI N, PENNA A, MURA G, LIBERATI A.Practice guidelines developed by speciality societies: the need for a critical appraisal. Lancet (2000) 355:103–106.